openPR Logo
Press release

Unfractionated Heparin Market to Record Sturdy Growth by 2025

08-23-2018 09:14 PM CET | Health & Medicine

Press release from: Transparency Market Research

Unfractionated Heparin Market to Record Sturdy Growth by 2025

The largely consolidated vendor landscape of the global Unfractionated Heparin Market features several large international companies and a handful of well-established local players operating in promising regional markets, states Transparency Market Research in a recent report. To gain a larger control on the market, companies are putting more emphasis on strategic collaborations and expansion in lucrative untapped regional markets. Focus on regional markets such as Asia Pacific and Latin America has thus significantly increased.

View Report -

Some of the leading companies in the market are Sagent Pharmaceuticals, Pfizer, Inc., Fresenius SE & Co. KGaA, B. Braun Melsungen AG, LEO Pharma A/S, and Baxter International Inc.

The report states that the market will exhibit a promising 6.4% CAGR over the period between 2017 and 2025, rising from a valuation of US$955.9 mn in 2016 to a revenue opportunity of US$1664.4 mn in 2025.

Request to View Sample of Report -

Steady Rise in Numbers of Cardiovascular Surgeries to Drive Market Globally

Unfractionated heparin, a naturally occurring anticoagulant, finds extensive usage in surgeries such as such as coronary artery bypass grafting and for the prevention and treatment of conditions such as pulmonary embolism, deep vein thrombosis, and arterial thromboembolism. In the past few years, there has been a vast rise in the prevalence of such conditions and the numbers continue to rise at an alarming pace. While it is hard to find the actual number of people affected by these conditions globally, studies show that nearly 900,000 people are affected by deep vein thrombosis in the U.S. alone every year. As the condition necessitates the use of unfractionated heparin, its rising prevalence, along with the increased incidence rate of other diseases requiring the use of unfractionated heparin, are expected to significantly drive the market.

The market for unfractionated heparin also benefits from the excellent functionality of the drug, its ability to get reversed, low cost, simple laboratory monitoring, and quick onset of action. The market for unfractionated heparin is also expected to be driven due to the rising demand across Europe and Asia Pacific as the geriatric population in these regions rises at a rapid pace. Moreover, the steady rise in the numbers of cardiovascular surgeries, which require unfractionated heparin as the preferred anticoagulant, is also expected to emerge as one of the leading driving factors for the market.

Request to View Brochure of Report -

Porcine-based Unfractionated Heparin Serves Maximum Demand

Unfractionated heparin is chiefly manufactured from bovine- and porcine-based sources. Of these, the segment of porcine based heparin accounted for the dominant share in the global market in terms of demand served and revenue contributed. This can be mainly attributed to the large-scale ban on the use of bovine-based unfractionated heparin in Europe and the U.S. for the past many years.

From a geographical standpoint, the market for unfractionated heparin in North America accounted for the dominant share in the overall market in 2016, mainly owing to the high prevalence of conditions associated with coagulation such as deep vein thrombosis and pulmonary embolism.

Enquiry for discount on this report -

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Unfractionated Heparin Market to Record Sturdy Growth by 2025 here

News-ID: 1198219 • Views: 275

More Releases from Transparency Market Research

Voltage Detectors Market – Evolving Technology Trends and Industry SWOT Analys …
The global voltage detectors market includes large number of players. Some of the key players are Texas Instruments, Toshiba, ROHM Semiconductor Sharp Microelectronics, Analog Devices Inc., STMicroelectronics, ON Semiconductor, Torex Semiconductor, Taiwan Semiconductor and Seiko Instruments. Browse Our Report @ Voltage Detector is a testing equipment generally used to determine the existence or absence of an electrical charge in an object. It is highly suggested for conditions where power issues exist.
Switched Capacitor Filters Market : Key Segments, Maket Insights, Regional Outlo …
Major players in the global switched capacitor filters market are Texas Instruments Incorporated, Analog Devices, Inc., Maxim Integrated, Inc., Siemens AG, Eaton Corporation, and among others. Browse Our Report @ A switched capacitor filter is an active filter based on the consideration that a switching of capacitors between two circuit nodes at an adequately high rate that is equivalent to a resistor connecting these two nodes. The switched capacitor filters are
Current Calibrator Market : Recent Industry Developments And Growth Strategies A …
Key players operating in the global current calibrator market include Valhalla Scientific, Rotek Inc., Time Electronics, PCE Instruments, Martel Electronics, AOIP Instrumentation, Extech Instruments, Yogokawa Test & Measurement Corporation, Extech Instruments, REED Instruments, Fluke Corporation, and others. These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the
Damp Meter Market – Outlook by Responsible Drivers, Restraints, Demand
Key players operating in the global damp meter market include PCE Instrument, Delmhorst Instrument Co., GENERAL TOOLS & INSTRUMENTS LLC, FLIR Systems, Inc. designs, Panomex Inc., These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the global market are collaborations, partnerships, agreements, and new product launches. The

All 5 Releases

More Releases for Unfractionated

Unfractionated Heparin Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ The global market size of Unfractionated Heparin is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand,
Unfractionated Heparin Market Outlook, and Opportunity Analysis, 2018-2026
Unfractionated heparin (UFH) is a natural agent widely used to prevent clot formation in vessels. Unfractionated heparin is a fast-acting blood thinner, which works with antithrombin, a natural protein in the body, to block clot formation. UFH is administered to patient intravenously into an arm vein or as a subcutaneous injection under the skin. UFH can also be administrated orally. However, oral absorption of unfractionated heparin is poor, owing to
Unfractionated Heparin Market Projected to be Resilient During 2025
Global Unfractionated Heparin Market: Overview This report on unfractionated heparin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing unfractionated heparin products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments
Global Unfractionated Heparin Market Assessment & Development Forecast during 20 …
Unfractionated heparin is known as a naturally occurring anticoagulant which is primarily in dialysis as well as heart lung machines for the prevention of blood clots. In order to study the market for unfractionated heparin, Market Research Hub (MRH) has included a new research report titled “Unfractionated Heparin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017- 2025”, to its wide database. This assessment studies the present
Unfractionated Heparin Market Overview and Regional Outlook Study by 2025
The vendor landscape of the global Unfractionated Heparin Market features a largely consolidated nature, with several large international vendors and a handful of local players operating in the market, observes Transparency Market Research in a recent report. With the view of maintaining their strongholds on the market, leading companies are focusing acquiring or entering into strategic mergers and collaborations with promising small-scale vendors in lucrative regional markets. Investments in regional
Global Unfractionated Heparin Market Insights: Premium Market Research Report 20 …
Reports Monitor publishes Global Unfractionated Heparin Market Report 2017-2022 to its database This report is split area wise globally and has included many important regions. The sales, revenue, market share and Growth rate of Unfractionated Heparin Marketof these regions from 2017 to 2022 (forecast) are North America Europe China Japan Southeast Asia India Request a Sample Copy of this Report @  The top competitors for Unfractionated Heparin Marketaccording to the sales volume, Price, (K USD /Unit), Revenue (Million USD),